[Symposium on future prospects of angiotensin converting enzyme. Presentation of perindopril, a new and potent ACE inhibitor. Perindopril exerts an efficacious and rapid inhibition of ACE in plasma as well as in tissues].
D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000818:Animals; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007211:Indoles / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D020913:Perindopril; D051381:Rats; D014018:Tissue Distribution
D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D007211:Indoles; D020913:Perindopril
Simposio sobre perspectivas de futuro de la enzima conversiva de la angiotensina. Presentación de perindopril, un nuevo y potente inhibidor de la ECA. Perindopril ejerce una eficaz y rápida inhibición de la ECA tanto en el plasma como en los tejidos.